Nirsevimab Library
This is a collection of current resources related to Nirsevimab.
RSV Prevention - Breakthroughs and Challenges
2023
· Vanderbilt University
This editorial discusses recent advances and ongoing challenges in preventing RSV, a common respiratory virus. The article highlights new methods being developed to protect people, …
Ask aRCie
Advocate to Vaccinate: Moving Away From the "Politics" of Vaccination
2024
· New York Medical College
This policy commentary focuses on promoting vaccines without political influence. It describes efforts to encourage vaccination, especially for children, while avoiding political debates that can …
Women's Acceptance of Two Strategies for Preventing Respiratory Syncytial Virus Infant Bronchiolitis: Maternal Immunization or Monoclonal Antibodies for Newborns
This article explores two ways to prevent respiratory syncytial virus (RSV) bronchiolitis in infants: through maternal immunization or giving monoclonal antibodies to newborns. It describes …
Prevention of RSV Bronchiolitis: An Ethical Issue
2024
· Bambino Gesu Children’s Hospital,
· University of Rome Tor Vergata,
· Bambino Gesù Children Hospital
The article describes the prevention of RSV bronchiolitis in infants using nirsevimab, a newly approved treatment. It highlights Galicia's successful immunization campaign, which significantly reduced …
The Pharmacist, a Key Player in the Fight Against the Respiratory Syncytial Virus
2024
This article highlights the important role pharmacists play in fighting respiratory syncytial virus (RSV), especially for infants and people over 60. It describes two main …
Effectiveness of Nirsevimab in Infants Against Respiratory Syncytial Virus and Related Events
2024
· Kaiser Permanente
This article discusses a study on nirsevimab, a treatment for infants to prevent respiratory syncytial virus (RSV), which is common in lower respiratory tract diseases. …
Cost-Effectiveness Analysis of Nirsevimab and RSVpreF Vaccine Prevention Strategies for Respiratory Syncytial Virus Disease in Infants: A Canadian Immunisation Research Network (CIRN) Study
2023
· York University,
· Yale University,
· Dalhousie University
This study looks at the cost-effectiveness of two strategies to prevent RSV disease in infants in Canada. It describes using nirsevimab, a long-acting antibody, for …
Coadministration of Anti-Viral Monoclonal Antibodies With Routine Pediatric Vaccines and Implications for Nirsevimab Use: A White Paper
2021
· University of Parma,
· University of British Columbia,
· University of Florence,
· Association Française de Pédiatrie Ambulatoire (AFPA),
· Launceston General Hospital,
· University of Tasmania
This article explores the use of anti-viral monoclonal antibodies (mAbs) with routine pediatric vaccines, focusing on nirsevimab for RSV prevention. It describes how mAbs can …
Nirsevimab Reduces Medically Attended RSV-Associated Lower Respiratory Tract Infection and Hospitalisations in Healthy Pre-Term Infants
2022
· University College Cork
This article comments on a study on how nirsevimab helps reduce RSV-related lung infections and hospital visits in healthy pre-term infants. It highlights the benefits …
Monoclonal Antibody for the Prevention of Respiratory Syncytial Virus in Infants and Children: A Systematic Review and Network Meta-analysis
2023
· Lanzhou University
This study reviews monoclonal antibodies (mAbs) for preventing respiratory syncytial virus (RSV) in infants and children. It describes how nirsevimab, motavizumab, and palivizumab reduce RSV-related …